These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10166407)

  • 1. The impact of drug therapy on quality of life in headache and migraine.
    Solomon GD; Litaker DG
    Pharmacoeconomics; 1997 Apr; 11(4):334-42. PubMed ID: 10166407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the measurement of quality of life in migraine.
    Solomon GD
    Neurology; 1997 Mar; 48(3 Suppl 3):S10-5. PubMed ID: 9071264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumatriptan. A pharmacoeconomic review of its use in migraine.
    Coukell AJ; Lamb HM
    Pharmacoeconomics; 1997 May; 11(5):473-90. PubMed ID: 10168035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in health-related quality of life with sumatriptan treatment for migraine.
    Jhingran P; Cady RK; Rubino J; Miller D; Grice RB; Gutterman DL
    J Fam Pract; 1996 Jan; 42(1):36-42. PubMed ID: 8537803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
    Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
    Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Chronic Daily Headache or Chronic Migraine.
    Cho SJ; Song TJ; Chu MK
    Curr Pain Headache Rep; 2016 Jan; 20(1):2. PubMed ID: 26695062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability and quality of life in different primary headaches: results from Italian studies.
    Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
    Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring disability and quality of life in migraine.
    Dahlöf CG
    Drugs Today (Barc); 2003; 39 Suppl D():17-23. PubMed ID: 15071616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine.
    Lofland JH; Kim SS; Batenhorst AS; Johnson NE; Chatterton ML; Cady RK; Kaniecki R; Nash DB
    Mayo Clin Proc; 2001 Nov; 76(11):1093-101. PubMed ID: 11702897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache-Specific Locus of Control and Migraine-Related Quality of Life: Understanding the Role of Anxiety.
    Grinberg AS; Seng EK
    Int J Behav Med; 2017 Feb; 24(1):136-143. PubMed ID: 27488417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan for the treatment of undifferentiated primary headaches in the ED.
    Miner JR; Smith SW; Moore J; Biros M
    Am J Emerg Med; 2007 Jan; 25(1):60-4. PubMed ID: 17157685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cycle of migraine: patients' quality of life during and between migraine attacks.
    Freitag FG
    Clin Ther; 2007 May; 29(5):939-949. PubMed ID: 17697913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine management in pregnancy.
    Ehi Y; Sahin L; Mutlu MF
    Clin Exp Obstet Gynecol; 2016; 43(5):661-665. PubMed ID: 30074315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.